Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 106.70
kr 9602.60kr 106.70
kr 1279.68
60 tablet
Free AirMail shipping Hot
kr 113.81
kr 6828.41kr 113.81
kr 426.44
30 tablet
Free AirMail shipping Hot
kr 120.91
kr 3627.43kr 120.91
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 128.04
kr 11523.19kr 128.04
kr 639.49
60 tablet
Free AirMail shipping Hot
kr 131.59
kr 7895.41kr 131.59
kr 213.04
30 tablet
Free AirMail shipping Hot
kr 135.14
kr 4054.23kr 135.14
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 152.93
kr 13763.88kr 152.93
kr 639.49
60 tablet
Free AirMail shipping Hot
kr 156.49
kr 9389.20kr 156.49
kr 213.04
30 tablet
Free AirMail shipping Hot
kr 160.04
kr 4801.12kr 160.04
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.